An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients. - Goi, Nobuhiro; Iwata, Fumino; Sugihara, Yoko; Higa, Shingo; Chikama, Taiichiro (Clinical Ophthalmology, 2024)